<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="717">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01965561</url>
  </required_header>
  <id_info>
    <org_study_id>H-13-016</org_study_id>
    <nct_id>NCT01965561</nct_id>
  </id_info>
  <brief_title>Performance of Junctional Tourniquets in Normal Human Volunteers</brief_title>
  <official_title>Performance of Junctional Tourniquets in Normal Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Institute of Surgical Research</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Army Institute of Surgical Research</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Normal human adult volunteers wereused to investigate the performance of medical devices
      intended to stop junctional bleeding on the battlefield.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Four FDA-cleared junctional tourniquets (Combat Ready Clamp (CRoC), Abdominal Aortic and
      Junctional Tourniquet (AAJT), Junctional Emergency Treatment Tool (JETT), and SAM Junctional
      Tourniquet (SJT)) wereassessed in a laboratory on healthy human volunteers. Lower extremity
      pulses were measured in 10 volunteers before and after junctional tourniquet application
      aimed at stopping the distal pulse assessed by Doppler auscultation. Tourniquets were
      applied in a randomized fashion, with 5 min rest periods between each application. Each
      tourniquet was applied to each subject, such that the subjects acted as their own controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Effectiveness at Stopping Distal Pulse</measure>
    <time_frame>1 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain During Tourniquet Application</measure>
    <time_frame>1 minute</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>- Hemorrhage</condition>
  <arm_group>
    <arm_group_label>CRoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Combat Ready Clamp (CRoC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AAJT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Abdominal Aortic and Junctional Tourniquet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>JETT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Junctional Emergency Treatment Tool</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SJT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SAM Junctional Tourniquet</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRoC</intervention_name>
    <description>Use of Combat Ready Clamp (CRoC)</description>
    <arm_group_label>CRoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AAJT</intervention_name>
    <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
    <arm_group_label>AAJT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JETT</intervention_name>
    <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
    <arm_group_label>JETT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJT</intervention_name>
    <description>Use of SAM Junctional Tourniquet (SJT)</description>
    <arm_group_label>SJT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult human volunteers who are recruited, screened, and consent to participate

          -  Ages at least 18 years old to no more than 60 years old (&lt;61) on the date of consent

          -  Male or female

          -  A worker for the US Military or US Government (active duty military, civilian
             employees, contractors)

        Exclusion Criteria:

          -  Active-duty military subjects without their supervisor's permission to participate

          -  Detainees or prisoners

          -  Evidence of major disease of an artery (e.g., artery or vein surgery, atherosclerotic
             disease diagnosis, stroke, peripheral vascular disease or dysfunction such as
             Reynaud's phenomenon, migraine headaches, or cardiovascular disease [uncontrolled
             hypertension, heart attack, or arrhythmias]), active abdominal, inguinal, gluteal, or
             thigh disease, major deformity, or hernias

          -  Pregnancy

          -  Contracted employees to the US Military or US Government without contractual
             permission to participate in the research
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John F Kragh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Army Institute of Surgical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>United States Army Institute of Surgical Research</name>
      <address>
        <city>JBSA Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234-7767</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 13, 2015</lastchanged_date>
  <firstreceived_date>October 15, 2013</firstreceived_date>
  <firstreceived_results_date>September 1, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>United States Army Institute of Surgical Research</investigator_affiliation>
    <investigator_full_name>John F. Kragh, Jr, MD</investigator_full_name>
    <investigator_title>Orthopedic Surgeon, Researcher</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Healthy human volunteers</population>
      <group_list>
        <group group_id="B1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat
Junctional Tourniquet</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>Age of healthy human volunteers</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="51" lower_limit="42" upper_limit="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Pain</title>
          <description>Pain level on Visual Analog Scale (0 mm = no pain, 100 mm = maximum pain)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="0" lower_limit="0" upper_limit="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness at Stopping Distal Pulse</title>
        <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
        <time_frame>1 min</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>CRoC</title>
            <description>Use of Combat Ready Clamp (CRoC)</description>
          </group>
          <group group_id="O2">
            <title>AAJT</title>
            <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
          </group>
          <group group_id="O3">
            <title>JETT</title>
            <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
          </group>
          <group group_id="O4">
            <title>SJT Tourniquet</title>
            <description>SAM Junctional Tourniquet (SJT)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="10"/>
                  <measurement group_id="O3" value="10"/>
                  <measurement group_id="O4" value="10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Effectiveness at Stopping Distal Pulse</title>
            <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="97"/>
                  <measurement group_id="O2" value="27"/>
                  <measurement group_id="O3" value="83"/>
                  <measurement group_id="O4" value="93"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain During Tourniquet Application</title>
        <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
        <time_frame>1 minute</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>CRoC</title>
            <description>Use of Combat Ready Clamp (CRoC)</description>
          </group>
          <group group_id="O2">
            <title>AAJT</title>
            <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
          </group>
          <group group_id="O3">
            <title>JETT</title>
            <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
          </group>
          <group group_id="O4">
            <title>SJT Tourniquet</title>
            <description>SAM Junctional Tourniquet (SJT)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="10"/>
                  <measurement group_id="O3" value="10"/>
                  <measurement group_id="O4" value="10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Pain During Tourniquet Application</title>
            <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
            <units>mm on VAS</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="30" spread="23"/>
                  <measurement group_id="O2" value="76" spread="14"/>
                  <measurement group_id="O3" value="45" spread="40"/>
                  <measurement group_id="O4" value="43" spread="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Rest = 5 minutes. SJT is belt with discs that inflate. JETT is belt with pads that screw down. AAT is an bladder within a belt. CRC is a vice.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>John Kragh, MD</name_or_title>
      <organization>USAISR</organization>
      <phone>210.539.2210</phone>
      <email>john.f.kragh.civ@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
